Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
Learn more about:
Related Clinical Trial
Expanded Access to Velmanase Alfa
Lamazym Aftercare Study
Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients
Evaluation of Long-term Efficacy of Treatment With Lamazym
Clinical Biomarkers in Alpha-mannosidosis
A Placebo-Controlled Phase 3 Trial of Repeated Lamazym Treatment of Subjects With Alpha-Mannosidosis
Long-term Efficacy and Safety of Lamazym for the Treatment of Patients With Alpha-Mannosidosis
Dose Finding Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis
Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
Biomarker for Mannosidosis Disease (BioMannosidosis)
Trial on Safety and Efficacy of Velmanase Alfa Treatment in Pediatric Patients With Alpha-Mannosidosis